# LITHIUM CARBONATE LITHIUM CARBONATE

NDC: 62332-014
Generic name: LITHIUM CARBONATE
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20161227

FDA application: ANDA079159

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ca2b977-b94c-4232-9b7e-835db97c9544